{"id":791,"date":"2026-09-01T17:35:05","date_gmt":"2026-09-01T17:35:05","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"melanotan-ii-human-pilot-toxicity-regulatory-evidence","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","title":{"rendered":"Melanotan II\u00a0:\u00a0Donn\u00e9es pilotes humaines, toxicit\u00e9 et statut r\u00e9glementaire"},"content":{"rendered":"
Melanotan II dispose de donn\u00e9es limit\u00e9es sur l\u2019exposition humaine pr\u00e9coce et de dommages document\u00e9s li\u00e9s \u00e0 une utilisation non r\u00e9glement\u00e9e. Un projet pilote de bronzage compos\u00e9 de trois personnes ne peut pas contrebalancer les rapports de toxicit\u00e9 ult\u00e9rieurs ou les avertissements actuels des r\u00e9gulateurs.<\/p>
Les preuves en un coup d'\u0153il<\/h2>
Le projet pilote en simple aveugle 1996 a recrut\u00e9 trois volontaires masculins en bonne sant\u00e9 et a utilis\u00e9 une solution saline altern\u00e9e ou des jours Melanotan II.<\/li>
\u00c0 0.03 mg\/kg, un participant sur deux pr\u00e9sentait une somnolence et une fatigue de grade II\u00a0; des naus\u00e9es et des \u00e9rections spontan\u00e9es prolong\u00e9es ont \u00e9galement \u00e9t\u00e9 rapport\u00e9es.<\/li>
Une exposition confirm\u00e9e \u00e0 6 mg chez un homme d'un an \u00e0 39 a \u00e9t\u00e9 suivie d'une tachycardie, d'un dysfonctionnement r\u00e9nal et d'une augmentation de CPK de 1,760 \u00e0 17,773 IU\/L.<\/li><\/ul><\/div><\/div>Illustration \u00e9ditoriale g\u00e9n\u00e9r\u00e9e par AI illustrant le flux de travail de recherche. Il ne s\u2019agit pas d\u2019une figure d\u2019\u00e9tude, d\u2019une image de patient, d\u2019une photographie de produit, d\u2019un r\u00e9sultat d\u2019analyse ou d\u2019un lot de catalogue.<\/figcaption><\/figure>
Dossier d'\u00e9tudes<\/h2>
Le projet pilote de phase I a \u00e9t\u00e9 con\u00e7u pour observer les effets \u00e0 court terme et non pour \u00e9tablir la s\u00e9curit\u00e9 de la population. Trois participants ne suffisent pas pour estimer les \u00e9v\u00e9nements ind\u00e9sirables rares, et le r\u00e9sultat ne valide pas les produits Internet actuels.<\/p>
Pilote 1996<\/strong>3 hommes en bonne sant\u00e9\u00a0; solution saline altern\u00e9e\/MT-II\u00a0; 0.01 \u00e0 0.025\u20130.03 mg\/kg<\/span><\/div>
Signaux pilotes<\/strong>Pigmentation dans 2\u00a0; naus\u00e9es, somnolence\/fatigue et \u00e9rections signal\u00e9es<\/span><\/div>
Cas 2012<\/strong>Homme de 39 ans\u00a0; 6 mg mat\u00e9riel achet\u00e9 sur Internet confirm\u00e9 par spectrom\u00e9trie de masse<\/span><\/div>
Limite r\u00e9glementaire<\/strong>FDA d\u00e9crit Melanotan II comme un nouveau m\u00e9dicament non approuv\u00e9\u00a0; TGA a trouv\u00e9 un contenu de produit en ligne incoh\u00e9rent<\/span><\/div><\/div><\/div>
R\u00e9sultats en contexte<\/h2>
Dans le cas toxicologique de 2012, la fr\u00e9quence cardiaque a atteint 146 battements par minute, la cr\u00e9atinine \u00e9tait de 2.25 mg\/dL, CPK a ensuite culmin\u00e9 \u00e0 17,773 IU\/L et le traitement de soins intensifs a dur\u00e9 trois jours. La spectrom\u00e9trie de masse a confirm\u00e9 Melanotan II par rapport \u00e0 une norme, renfor\u00e7ant l'attribution de l'exposition tout en restant un cas unique.<\/p>
En ao\u00fbt, 2026, le journal australien TGA a signal\u00e9 que cinq flacons pour pulv\u00e9risation nasale saisis, \u00e9tiquet\u00e9s 30 mg, contenaient des quantit\u00e9s estim\u00e9es allant de 22 \u00e0 54 mg. Cette incoh\u00e9rence r\u00e9elle constitue un risque li\u00e9 \u00e0 la qualit\u00e9 du produit et au dosage, distinct de la pharmacologie de la mol\u00e9cule.<\/p>
Ce que la preuve ne peut \u00e9tablir<\/h2>
L'\u00e9chantillon pilote de trois ne peut pas \u00e9tablir l'innocuit\u00e9 ou l'efficacit\u00e9.<\/p>
Un rapport de cas ne peut pas estimer l\u2019incidence, mais il peut documenter un \u00e9v\u00e9nement grave plausible.<\/p>
Le contenu d'un produit non r\u00e9glement\u00e9 ne peut pas \u00eatre d\u00e9duit d'une \u00e9tiquette, et les documents de recherche sur catalogue ne sont pas des m\u00e9dicaments approuv\u00e9s.<\/p>","protected":false},"excerpt":{"rendered":"
Melanotan II dispose de donn\u00e9es limit\u00e9es sur l\u2019exposition humaine pr\u00e9coce et de dommages document\u00e9s li\u00e9s \u00e0 une utilisation non r\u00e9glement\u00e9e. Un projet pilote de bronzage compos\u00e9 de trois personnes ne peut pas contrebalancer les rapports de toxicit\u00e9 ult\u00e9rieurs ou les avertissements actuels des r\u00e9gulateurs.<\/p>","protected":false},"author":1,"featured_media":775,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"350","pim_article_type":"Published evidence review","pim_evidence_level":"Three-person phase I pilot, case reports and current regulatory safety warnings","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits and regulatory scope are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 4.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"Melanotan II pilot phase I study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/8637402\/\",\"note\":\"Three-person single-blind pilot; PMID 8637402.\"},{\"title\":\"Melanotan II systemic toxicity and rhabdomyolysis\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23121206\/\",\"note\":\"Mass-spectrometry-confirmed case report; PMID 23121206.\"},{\"title\":\"TGA finds inconsistent Melanotan II content\",\"url\":\"https:\/\/www.tga.gov.au\/safety\/safety-monitoring-and-information\/safety-alerts\/melanotan-ii-tanning-peptide-products-found-be-inconsistently-dosed\",\"note\":\"Official August 2026 laboratory-testing safety alert.\"},{\"title\":\"FDA Melanotan II enforcement record\",\"url\":\"https:\/\/www.fda.gov\/regulatory-information\/electronic-reading-room\/notice-opportunity-hearing-nooh-manookian-edward-8516\",\"note\":\"Official record describing Melanotan II as an unapproved new drug.\"},{\"title\":\"PubChem Melanotan II record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/melanotan-II\",\"note\":\"Cyclic sequence, formula and molecular weight; CID 92432.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-791","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\n
Melanotan II: Human Pilot Data, Toxicity and Regulatory Status<\/title>\n<meta name=\"description\" content=\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\" \/>\n<meta property=\"og:description\" content=\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T17:35:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1672\" \/>\n\t<meta property=\"og:image:height\" content=\"941\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\",\"name\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"datePublished\":\"2026-09-01T17:35:05+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/melanotan-ii-evidence.webp\",\"width\":1672,\"height\":941,\"caption\":\"AI-generated illustration: clinical-toxicology case review\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Melanotan II\u00a0:\u00a0Donn\u00e9es pilotes humaines, toxicit\u00e9 et statut r\u00e9glementaire","description":"Melanotan II dispose de donn\u00e9es limit\u00e9es sur l\u2019exposition humaine pr\u00e9coce et de dommages document\u00e9s li\u00e9s \u00e0 une utilisation non r\u00e9glement\u00e9e. Un projet pilote de bronzage \u00e0 trois personnes ne peut pas contrebalancer la toxicit\u00e9 ult\u00e9rieure\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","og_locale":"fr_FR","og_type":"article","og_title":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status","og_description":"Melanotan II has limited early human exposure data and documented harms from unregulated use. A three-person tanning pilot cannot outweigh later toxicity r\u2026","og_url":"https:\/\/nhdbio.com\/fr\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","og_site_name":"NHD","article_published_time":"2026-09-01T17:35:05+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1672,"height":941,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","url":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/","name":"Melanotan II\u00a0:\u00a0Donn\u00e9es pilotes humaines, toxicit\u00e9 et statut r\u00e9glementaire","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","datePublished":"2026-09-01T17:35:05+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Melanotan II dispose de donn\u00e9es limit\u00e9es sur l\u2019exposition humaine pr\u00e9coce et de dommages document\u00e9s li\u00e9s \u00e0 une utilisation non r\u00e9glement\u00e9e. Un projet pilote de bronzage \u00e0 trois personnes ne peut pas contrebalancer la toxicit\u00e9 ult\u00e9rieure\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp","width":1672,"height":941,"caption":"AI-generated illustration: clinical-toxicology case review"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/melanotan-ii-human-pilot-toxicity-regulatory-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Melanotan II: Human Pilot Data, Toxicity and Regulatory Status"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/791","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=791"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/791\/revisions"}],"predecessor-version":[{"id":1196,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/791\/revisions\/1196"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/775"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=791"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=791"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=791"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Revue](\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/melanotan-ii-evidence.webp\")